NCT00667147 - Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2014

Conditions

Solid Tumors

Interventions

DRUG

Weekly Abraxane and Daily Vandetanib

Abraxane once a week for three weeks, followed by one week with no Abraxane. Vandetanib once a day every day for 28 days. This four week period is called a cycle.

DRUG

Abraxane every three weeks and daily vandetanib

Abraxane on day one of study therapy, followed by 20 days of no Abraxane. Vandetanib once a day every day for 21 days. This three week period is called a cycle.

Trial Locations (1)

90033

University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center, Los Angeles